Immediate Impact

3 by Nobel laureates 2 from Science/Nature 63 standout
Sub-graph 1 of 22

Citing Papers

New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
Theranostic Fluorescent Probes
2024 Standout
2 intermediate papers

Works of Donna LeBherz being referenced

Phase I Trial of the Anti–Lewis Y Drug Immunoconjugate BR96-Doxorubicin in Patients With Lewis Y–Expressing Epithelial Tumors
2000

Author Peers

Author Last Decade Papers Cites
Donna LeBherz 185 111 129 8 320
Gadi Gazit Bornstein 186 103 100 8 327
Frans V. Suurs 192 114 197 11 339
Joerg Bruenke 174 178 130 12 326
Ganesh M. Shankar 165 233 69 8 359
Robin Goldman-Leikin 203 71 100 13 335
Hong Hoi Ting 236 93 179 9 358
Candice Limper 72 139 128 10 323
Xiao-Tao Yao 92 134 129 8 281
Timothy M. Pierpont 74 111 138 10 355
Emily Y. Jen 50 79 144 9 308

All Works

Loading papers...

Rankless by CCL
2026